Compounds > fluorodeoxyglucose f18
Page last updated: 2024-08-24

fluorodeoxyglucose f18 and arbutamine

fluorodeoxyglucose f18 has been researched along with arbutamine in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Adams, S; Baum, RP; Hör, G; Scholz, M; Zeiher, AM1
De Landsheere, CM; Degueldre, C; Kulbertus, HE; Lancellotti, P; Melon, PG; Pierard, LA1

Other Studies

2 other study(ies) available for fluorodeoxyglucose f18 and arbutamine

ArticleYear
[Functional/metabolic CAD diagnosis: arbutamine-RNV, stress-Echo, Tl-SPECT and gated FDG-PET].
    Nuklearmedizin. Nuclear medicine, 1997, Volume: 36, Issue:4

    Topics: Catecholamines; Coronary Disease; Deoxyglucose; Echocardiography; Exercise Test; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Gated Blood-Pool Imaging; Heart; Humans; Male; Middle Aged; Myocardial Revascularization; Myocardium; Radiography, Thoracic; Radionuclide Ventriculography; Thallium Radioisotopes; Tomography, Emission-Computed, Single-Photon

1997
Identification of viable myocardium early after acute myocardial infarction using closed-loop arbutamine echocardiography: comparison with positron emission tomography.
    Acta cardiologica, 2001, Volume: 56, Issue:6

    Topics: Adrenergic beta-Agonists; Catecholamines; Echocardiography; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Myocardial Contraction; Myocardial Infarction; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed

2001